- Home
- BOTJ vs ARTV Comparison
BOTJ vs ARTV Comparison
Compare BOTJ & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- ARTV
- Stock Information
- Founded
- BOTJ 1998
- ARTV 2019
- Country
- BOTJ United States
- ARTV United States
- Employees
- BOTJ N/A
- ARTV N/A
- Industry
- BOTJ Major Banks
- ARTV
- Sector
- BOTJ Finance
- ARTV
- Exchange
- BOTJ Nasdaq
- ARTV NYSE
- Market Cap
- BOTJ 63.5M
- ARTV 61.9M
- IPO Year
- BOTJ N/A
- ARTV 2024
- Fundamental
- Price
- BOTJ $14.10
- ARTV $2.13
- Analyst Decision
- BOTJ
- ARTV Strong Buy
- Analyst Count
- BOTJ 0
- ARTV 7
- Target Price
- BOTJ N/A
- ARTV $20.00
- AVG Volume (30 Days)
- BOTJ 2.8K
- ARTV 213.6K
- Earning Date
- BOTJ 04-30-2025
- ARTV 05-08-2025
- Dividend Yield
- BOTJ 2.79%
- ARTV N/A
- EPS Growth
- BOTJ N/A
- ARTV N/A
- EPS
- BOTJ 1.45
- ARTV N/A
- Revenue
- BOTJ $45,083,000.00
- ARTV N/A
- Revenue This Year
- BOTJ N/A
- ARTV N/A
- Revenue Next Year
- BOTJ N/A
- ARTV N/A
- P/E Ratio
- BOTJ $9.79
- ARTV N/A
- Revenue Growth
- BOTJ 4.72
- ARTV N/A
- 52 Week Low
- BOTJ $10.14
- ARTV $1.78
- 52 Week High
- BOTJ $17.05
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- BOTJ 53.87
- ARTV N/A
- Support Level
- BOTJ $13.81
- ARTV N/A
- Resistance Level
- BOTJ $14.39
- ARTV N/A
- Average True Range (ATR)
- BOTJ 0.33
- ARTV 0.00
- MACD
- BOTJ 0.03
- ARTV 0.00
- Stochastic Oscillator
- BOTJ 74.56
- ARTV 0.00
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).